Dogs, like humans, can develop cancer as they age. In fact, cancer is one of the most common diseases affecting dogs. Certain breeds may be more susceptible to cancer, including Golden Retrievers, Boxers, Rottweilers, and German Shepherds. Some of the most prevalent types of cancer in dogs include lymphoma and hemangiosarcoma.

Regular screenings for cancer lead to early detection, especially in breeds at higher risk. Early diagnosis through dog cancer screenings increases the likelihood of successful treatment to keep your beloved canine with you for longer.

The Nu.Q® Canine Cancer Screening is a groundbreaking, blood-based test that detects the signs of seven types of cancer in dogs. This dog cancer screening measures nucleosome levels in the blood—biomarkers that can indicate the presence of cancer. The test is a simple blood draw, making the process quick and easy for your dog.

Nu.Q® has been shown to be effective in detecting cancer, with an 77% detection rate for lymphoma and 82% for hemangiosarcoma, which are among the most aggressive cancers in dogs. This cancer test for dogs allows for detection at early stages, even before symptoms become noticeable.